Microplastics and Misinformation: What Science Really Says
November 12, 2025
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Brand Name :
Morniflu
Synonyms :
morniflumate
Class :
NSAID’s, Antipyretic agent
Brand Name :
Morniflu
Synonyms :
morniflumate
Class :
NSAID’s, Antipyretic agent
Dosage Forms & StrengthsÂ
TabletÂ
200 mgÂ
400 mgÂ
350 mgÂ
SuppositoryÂ
500 mgÂ
285 mgÂ
Multisystem Inflammatory Syndrome (MIS)Â
Administer a dose of 500 mg in the form of suppositories twice daily
Dosage Forms & StrengthsÂ
TabletÂ
200 mgÂ
400 mgÂ
350 mgÂ
SuppositoryÂ
500 mgÂ
285 mgÂ
Multisystem Inflammatory Syndrome (MIS)Â
For <4 years old:
Administer a dose of 175 mg one time a day
For 4 to 8 years old:
Administer a dose of 175 mg twice a day
For 8 to 14 years old:
Administer a dose of 350 mg twice a day
For geriatrics above 65 with typically diminished renal function and reduced gastrointestinal tract tolerability to nonsteroidal anti-inflammatory drugs, the suggested dosage is 350 milligrams twice or three times daily, adjusted based on the severity of symptoms requiring treatment
Multisystem Inflammatory Syndrome (MIS)Â
For geriatrics above 65 with typically diminished renal function and reduced gastrointestinal tract tolerability to nonsteroidal anti-inflammatory drugs, the suggested dosage is 350 milligrams twice or three times daily, adjusted based on the severity of symptoms requiring treatment
Dose Adjustments
Limited data is available
morniflumate may reduce the excretion rate of amrinone, potentially leading to an elevated serum level
the chances of bleeding can be heightened when morniflumate is administered in conjunction with anagrelide
morniflumate may decrease the excretion rate of ancestim, resulting in a potential increase in serum levels
the chances of adverse effects can be heightened when antipyrine is combined with morniflumate
the chances of bleeding and hemorrhage may be increased when morniflumate is used in conjunction with antithrombin alfa
the chances of bleeding and hemorrhage can be heightened when morniflumate is combined with antithrombin iii human
the chances of adverse effects may be increased when antrafenine is combined with morniflumate
Actions and Spectrum:Â
Morniflumate has antipyretic properties. In bronchitis cases it shows improvement in terms of physical examination. Â
Frequency not defined Â
DiarrheaÂ
EdemaÂ
MelaenaÂ
VomitingÂ
NauseaÂ
IndigestionÂ
Black box warning:Â
None Â
Contraindication/Caution:Â
It is contraindicated in following situations:Â
HypersensitivityÂ
Active duodenal or gastric ulcerÂ
Active GI bleedingÂ
Pregnancy Warnings:Â Â
Pregnancy category: N/AÂ Â
Lactation:Â Â
Excretion of the drug in human breast milk is unknown Â
Pregnancy Categories:Â Â Â Â
Category A: Satisfactory and well-controlled studies show no evidence of risk to the fetus in the first trimester or in the later trimester.   Â
<b>Category B: No evidence of risk to fetus found in animal reproduction studies and there are not enough studies on pregnant women.   Â
Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for an effect in humans, care must be taken for potential risks in pregnant women.   Â
Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite potential risks may be used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category clearly outweigh risks over benefits. These category drugs should be prohibited for pregnant women.   Â
Category N: There is no data available for the drug under this category. Â
Pharmacology:Â
Morniflumate is evaluated for its effect on leukotriene B4 and thromboxane synthesis in purified polymorphonuclear neutrophils and whole blood. Â
Pharmacodynamics:Â
This influences cyclooxygenase and 5-lipoxygenase thus they effectively reduce arachidonic acid metabolism.Â
Pharmacokinetics:Â
Limited information available on ADME.Â
Administration:Â
The drug is available in oral dosage form and as suppositories. Â
 Patient information leafletÂ
Generic Name: morniflumateÂ
Why do we use morniflumate?Â
Morniflumate is indicated for treatment of multisystem inflammatory syndrome. Â
It is beneficial in the treatment of inflammatory conditions of the airways and related to ear, nose and throat. Â
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
